TruDiagnostic
PrivateLast Round
Grant
Mar 3, 2022
Total Funding Raised
$5.1M
Company Overview
TruDiagnostic operates in Healthcare & Life Sciences and is based in Lexington, Kentucky. Its latest recorded funding round was a Grant round in March 2022.
TruDiagnostic is a health data company that provides epigenetic testing and research services to measure biological age and other health insights.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Hardware + Subscription, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TruDiagnostic Comparables
Compare TruDiagnostic with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlycanAge | 87% | |
| Muhdo Health | 84% | |
| EpiMedTech Global | 81% |
For institutional investors. Book with your work email.
TruDiagnostic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 3, 2022 | ||||
| Seed | Jun 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TruDiagnostic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Kentucky Science and Technology Corporation | Grant |
| Kentucky Cabinet for Economic Development | Grant |
| Kentucky Science and Engineering Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
Grew 18% QoQ, from 51 to 60 employees.
- Jan 21, 2026
Grew 21% QoQ, from 48 to 58 employees.
For institutional investors. Book with your work email.
TruDiagnostic Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TruDiagnostic's valuation, stock price, and market status.
Is TruDiagnostic a public or private company?
TruDiagnostic is a private company.
What is the current stock price of TruDiagnostic?
TruDiagnostic is a private company, so its shares have no public market price. Caplight tracks TruDiagnostic's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TruDiagnostic worth (valuation)?
Valuation information for TruDiagnostic is not publicly available.
Can I buy TruDiagnostic stock?
TruDiagnostic shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TruDiagnostic's last funding round?
TruDiagnostic's most recent funding round was Grant on March 3, 2022.
Who are the main investors in TruDiagnostic?
Key investors in TruDiagnostic include NIH RADx, Kentucky Science and Technology Corporation, Kentucky Cabinet for Economic Development, Kentucky Science and Engineering Foundation.
Will TruDiagnostic IPO soon?
No public IPO plans have been announced for TruDiagnostic.
How can I track TruDiagnostic secondary market activity?
Caplight tracks bids, offers, and trades in TruDiagnostic's shares on secondary markets.